SAPHNELO sol inj 120 mg/0.8ml stylo pré 4 pce

7680702780023 CH-70278 L04AG11 07.15.0.

Active substances:

No images available

Details

Product number
7027801
CPT
-
Packaging group
4
Unit
Injektor(en), vorgefüllt/Pen
Composition
anifrolumabum 120 mg, histidinum, histidini hydrochloridum monohydricum, lysini hydrochloridum, trehalosum dihydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml.

Articles (1)

Saphnelo 120 mg/0.8 ml, Injektionslösung in einem Fertigpen
Injektionslösung in einem Fertigpen
4
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/07/2026
Patient information leaflet
Français
29/07/2026
Patient information leaflet
Italien
29/07/2026

Detailed composition

Substance Quantity Type Category
anifrolumabum
120.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
lysini hydrochloridum
- Substance HNIDK
trehalosum dihydricum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 990.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2026

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
70278
Drug name
Saphnelo, Injektionslösung in einem Fertigpen
Galenic form
INLFP
ATC Code
L04AG11
Authorization status
Z
Dispensation category
B
First authorization
12/05/2026
Authorization expiration date
11/05/2031
IT number
07.15.0.
Domain
Human medicine
Field of application
Systemischer Lupus erythematodes (SLE)

Packaging details

Description (FR)
SAPHNELO sol inj 120 mg/0.8ml stylo pré 4 pce
Description (DE)
SAPHNELO Inj Lös 120 mg/0.8ml Fertpen 4 Stk
Market launch
31/07/2026
Narcotic (BTM)
No

Other packaging sizes

SAPHNELO sol inj 120 mg/0.8ml stylo pré 1 pce
1 INJ
View
Buy us a coffee Explore the data